½ÃÀ庸°í¼­
»óǰÄÚµå
1441432

¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Á¶»ç ¹× ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Wearable Medical Devices Market Size study & Forecast, by Product, by Application, by Distribution Channel and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀº 2022³â¿¡ ¾à 591¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø±â°£(2023³â-2030³â) µ¿¾È 28.6% ÀÌ»óÀÇ °ß½ÇÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ÀÇ·á±â±â´Â °Ç°­°ú ÇູÀÇ ´Ù¾çÇÑ Ãø¸éÀ» ¸ð´ÏÅ͸µ, °ü¸® ¹× °³¼±Çϱâ À§ÇØ ½Åü¿¡ ÀåÂøÇϵµ·Ï ¼³°èµÈ ÈÞ´ë¿ë ¹× ¼ÒÇü ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡¿¡´Â ÀϹÝÀûÀ¸·Î ¼¾¼­, µ¥ÀÌÅÍ Ã³¸® ±â´É ¹× ¹«¼± ¿¬°áÀÌ ³»ÀåµÇ¾î ÀÖÀ¸¸ç ½Ç½Ã°£ °Ç°­ Á¤º¸¸¦ ¼öÁý ¹× Àü¼ÛÇÕ´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ½É¹Ú¼ö, Ç÷¾Ð, »ê¼Ò ³óµµ µîÀÇ »ýü »çÀÎ ¸ð´ÏÅ͸µ, ½Åü Ȱµ¿ ¹× ¼ö¸é ÆÐÅÏ ÃßÀû, ´ç´¢º´ ¹× È£Èí±â Áúȯ°ú °°Àº ¸¸¼º Áúȯ °ü¸® µî ´Ù¾çÇÑ ¸ñÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ´Â ¹è°æ¿¡´Â ¸¸¼º ÁúȯÀÇ À¯º´·ü »ó½Â, ÀÏ¹Ý ÁÖ¹ÎÀÇ °Ç°­ ÀÇ½Ä Áõ°¡, ÇÇÆ®´Ï½º µ¿Çâ Áõ°¡ µîÀÇ ¿äÀÎÀÌ ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀº ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÇ ¼ºÀåÀ» Áö¿øÇÏ´Â Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â Áúȯ µîÀÇ ¸¸¼º ÁúȯÀº ¼¼°èÀûÀ¸·Î Á¡Á¡ ´õ È®»êµÇ°í ÀÖÀ¸¸ç °Ç°­ °ü¸® ½Ã½ºÅÛ¿¡ Å« ºÎ´ãÀ»ÁÖ°í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ÀÇ·á±â±â´Â ÀÌ·¯ÇÑ Áõ»óÀ» °ü¸®ÇÏ´Â °³Àο¡°Ô ¿¹¹æÀûÀ̰í Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. Ȱ·Â ¡ÈÄ, Ȱµ¿ ¼öÁØ ¹× ±âŸ °ü·Ã °Ç°­ ÁöÇ¥¿Í °°Àº ÀÌ·¯ÇÑ Àåºñ¿¡¼­ Á¦°øµÇ´Â ½Ç½Ã°£ µ¥ÀÌÅÍ´Â ÀáÀçÀûÀÎ ÇÕº´ÁõÀÇ Á¶±â ¹ß°ßÀ» °¡´ÉÇÏ°Ô Çϰí Àû½Ã °³ÀÔÀ» ÃËÁøÇÕ´Ï´Ù. ±¹Á¦´ç´¢º´¿¬ÇÕ(International Diabetes Federation)ÀÇ 'Diabetes Atlas Tenth Edition 2021'¿¡ µû¸£¸é 2021³â¿¡´Â ¼¼°è¿¡¼­ ¾à 5¾ï 3,700¸¸¸íÀÇ ¼ºÀο¡°Ô ´ç´¢º´ÀÌ ¹ß°ßµÇ¾úÀ¸¸ç, 2030³â¿¡´Â 6¾ï 4,300¸¸¸í, 2045 ³â¿¡´Â 7¾ï 8,300¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. °Ô´Ù°¡ ¹Ì±¹ ½ÉÀ庴ÇÐȸ(The American College of Cardiology)ÀÇ º¸°í¿¡ µû¸£¸é, 2021³â¿¡´Â 695¸¸¸íÀ̾ú´ø ½ÉÇ÷°ü ÁúȯÀÇ Áø´ÜÀ» ¹ÞÀº ¹Ì±¹ÀÎÀº 2030³â¿¡´Â ¾à 2,900¸¸¸íÀÌ µÈ´Ù°í ÁÁ¾Æ. 2020³â¿¡´Â Àü ¼¼°èÀûÀ¸·Î 2¾ï 4,410¸¸ ¸íÀÌ ÇãÇ÷¼º ½ÉÀå ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½ÂÀÌ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½º¸¶Æ®Æù°ú Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°úÀÇ ÅëÇÕ, °í·ÉÈ­ Àα¸ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª µ¥ÀÌÅÍ º¸¾È°ú ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í Á¦ÇÑµÈ »óȯ Á¤Ã¥Àº 2023³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Á¶»ç¿¡¼­ °í·ÁÇÑ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â 2022³â¿¡ ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ½ÉÇ÷°ü Àå¾Ö, ´ç´¢º´, ¾ÏÀÇ ÀÌȯÀ²ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ºó¹øÇÑ Åë¿øÀÇ Çʿ伺À» ÃÖ¼ÒÈ­Çϸ鼭 ÀϰüµÇ°í Áö¼ÓÀûÀ̰í Àå±â°£ÀÇ È¯ÀÚ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÏ´Â ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¹× ÀçÅà ÄÉ¾î ±â±âÀÇ º¸±ÞÀº ¿¹Ãø ±â°£À» ÅëÇØ ½ÃÀå È®´ë¸¦ ´õ ¹Ð¾î ³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ª ½ÃÀåÀº ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ »ç¿ëÀ» ÃËÁøÇÏ´Â Á¤ºÎÀÇ Áö¿øÃ¥, ³ëÀÎ Àα¸ Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, ±Þ¼ÓÇÑ ±â¼ú Áøº¸, ÀçÅà ÄÉ¾î ±â±â ¼ö¿ä Áõ°¡, Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺 µîÀÇ ¿äÀο¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³âµ¿¾È ´Ù¾çÇÑ ºÎ¹®¿Í ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ Á¤ÀÇÇÏ°í ¾ÕÀ¸·Î ¸î ³â°£ÀÇ °¡Ä¡¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡¿¡¼­ »ê¾÷ÀÇ ÁúÀû ¹× ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î½ÃÀåÀÇ ÀáÀçÀûÀÎ ±âȸµµ Æ÷ÇÔÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³âµµ
  • ȯÀ² º¯È¯À²

Á¦3Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå ¿ªÇÐ

  • ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀåÀÇ ¿µÇ⠺м®(2020³â-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼ºÁúȯÀÇ À¯º´·ü »ó½Â
      • ÀÏ¹Ý Àα¸ÀÇ °Ç°­ ÀǽÄÀÌ Áõ°¡
      • ÇÇÆ®´Ï½º µ¿Çâ Áõ°¡
    • ½ÃÀåÀÇ °úÁ¦
      • µ¥ÀÌÅÍ º¸¾È ¹× °³ÀÎÁ¤º¸ º¸È£¿¡ ´ëÇÑ ¿ì·Á
      • ÇÑÁ¤µÈ »óȯÁ¤Ã¥
    • ½ÃÀå ±âȸ
      • ½º¸¶Æ®ÆùÀ̳ª Ŭ¶ó¿ìµå ÄÄÇ»ÆÃ°úÀÇ ÅëÇÕ
      • °í·ÉÈ­ Àα¸ Áõ°¡

Á¦4Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
    • ±¸¸ÅÀÚÀÇ Çù»ó·Â
    • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five ForcesÀÇ ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Á¦Ç°º°, ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
  • ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Áø´Ü,ȯÀÚ ¸ð´ÏÅ͸µ ±â±â
    • Ä¡·á¿ë µð¹ÙÀ̽º

Á¦6Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ¿ëµµº°, ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
  • ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú ÀçÅà °Ç°­ °ü¸®
    • ½ºÆ÷Ã÷¿Í ÇÇÆ®´Ï½º

Á¦7Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : À¯Åë ä³Îº°

  • ½ÃÀå ÇöȲ
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : À¯Åë ä³Îº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : À¯Åë ä³Îº°, ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
  • ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ¼Ò¸Å ¾à±¹
    • ¿Â¶óÀÎ À¯Åë
    • ÇÏÀÌÆÛ¸¶ÄÏ

Á¦8Àå ¼¼°è ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä±¹
  • ÁÖ¿ä ½ÅÈï±¹
  • ¿þ¾î·¯ºí ÀÇ·á±â±â ½ÃÀå :Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç°º° ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
      • ¿ëµµº° ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
      • À¯Åë ä³Îº° ÃßÁ¤ ¹× ¿¹Ãø(2020³â-2030³â)
    • ij³ª´Ù
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Apple Inc
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍÀÇ À̿밡´É¼º¿¡ µû¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Samsung Electronics Co., Ltd
    • Garmin Ltd.
    • Abbott Laboratories
    • Medtronic plc
    • Dexcom, Inc
    • Johnson & Johnson Inc.
    • Philips Healthcare
    • Xiaomi Corporation
    • Intelesens Ltd.

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
BJH 24.03.29

Global Wearable Medical Devices Market is valued at approximately USD 59.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 28.6% during the forecast period 2023-2030. A wearable medical device is a portable and compact technology designed to be worn on the body to monitor, manage, or improve various aspects of health and well-being. These devices typically incorporate sensors, data processing capabilities, and wireless connectivity to collect and transmit real-time health information. Wearable medical devices can serve a range of purposes, including monitoring vital signs such as heart rate, blood pressure, and oxygen levels, tracking physical activity and sleep patterns, and managing chronic conditions such as diabetes or respiratory disorders. The Wearable Medical Devices Market is expanding because of factors such as the rising prevalence of chronic disorders, rising health consciousness among the general population and growing fitness trends.

The rising prevalence of chronic diseases is a significant driving force behind the growth of the Wearable Medical Devices Market. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent worldwide, placing a substantial burden on healthcare systems. Wearable medical devices offer a proactive and continuous monitoring solution for individuals managing these conditions. The real-time data provided by these devices, including vital signs, activity levels, and other relevant health metrics, enable early detection of potential complications and facilitate timely intervention. According to the International Diabetes Federation, Diabetes Atlas Tenth Edition 2021, about 537 million adults worldwide were discovered to have diabetes in 2021, with estimates showing that figure would rise to 643 million by 2030 and 783 million by 2045. Moreover, The American College of Cardiology reports that by 2030, there would be around 29 million Americans with a diagnosis of cardiovascular disease, up from 6.95 million in the year 2021. In 2020, 244.1 million people worldwide were living with ischemic heart disease. Thus, the rising prevalence of chronic conditions is driving the market growth. In addition, integration with smartphones and cloud computing and the rising aging population are creating new opportunities for market growth. However, data security and privacy concerns and limited reimbursement policies stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Wearable Medical Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The increasing incidence of cardiovascular disorders, diabetes, and cancer in this region is expected to drive market growth. The widespread adoption of remote patient monitoring and home care devices, aimed at providing consistent, continuous, and prolonged patient monitoring while minimizing the need for frequent hospital visits, is anticipated to further boost market expansion throughout the forecast period. Asia Pacific is expected to grow significantly over the forecast period. The market in the region is being driven by factors such as supportive government initiatives promoting the use of wearable medical instruments, a rising elderly population, and escalating healthcare expenditures, rapid technological advancements, increasing demand for home care devices, and the necessity for continuous monitoring.

Major market player included in this report are:

  • Apple Inc
  • Samsung Electronics Co., Ltd
  • Garmin Ltd.
  • Abbott Laboratories
  • Medtronic plc
  • Dexcom, Inc
  • Johnson & Johnson Inc.
  • Philips Healthcare
  • Xiaomi Corporation
  • Intelesens Ltd.

Recent Developments in the Market:

  • In January 2023, Masimo and Royal Philips have extended their collaboration to leverage the features of the Masimo W1 advanced health tracking watch, with the goal of improving patient monitoring in the domain of home telehealth. The amalgamation of Philips's enterprise patient monitoring ecosystem with the W1 watch is poised to drive progress in telehealth and telemonitoring capabilities. This collaboration signals a concerted effort to enhance the effectiveness and reach of remote health monitoring solutions
  • In April 2023, Garmin disclosed the expanded regional availability of Dexcom Connect IQ apps, catering to individuals managing Type 1 or Type 2 diabetes and utilizing the Dexcom G6 or Dexcom G7 Continuous Glucose Monitoring System. These apps empower users to conveniently monitor their glucose levels and trends directly on a compatible smartwatch or cycling computer.
  • In July 2021, Semglee, a first-of-its-kind Wearable Medical Devices product made by India's Biocon, got United States approval. Semglee, manufactured by Biocon Biologics, a Bengaluru-based pharmaceutical company, is both interchangeable with and biosimilar to Lantus, a long-acting Wearable Medical Devices product already approved in the United States.

Global Wearable Medical Devices Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Application, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Diagnostic & Patient Monitoring Devices
  • Therapeutic Devices

By Application:

  • Remote Patient Monitoring & Home Healthcare
  • Sports and Fitness

By Distribution Channel:

  • Retail Pharmacies
  • Online Distribution
  • Hypermarkets

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Wearable Medical Devices Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Wearable Medical Devices Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Wearable Medical Devices Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Wearable Medical Devices Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Wearable Medical Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Wearable Medical Devices Market Dynamics

  • 3.1. Wearable Medical Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of chronic disorders
      • 3.1.1.2. Rising health consciousness among general population
      • 3.1.1.3. Growing fitness trends
    • 3.1.2. Market Challenges
      • 3.1.2.1. Data security and privacy concerns
      • 3.1.2.2. Limited reimbursement policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Integration with smartphones and cloud computing
      • 3.1.3.2. Rising aging population

Chapter 4. Global Wearable Medical Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Wearable Medical Devices Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Wearable Medical Devices Market by Product, Performance - Potential Analysis
  • 5.3. Global Wearable Medical Devices Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Wearable Medical Devices Market, Sub Segment Analysis
    • 5.4.1. Diagnostic & Patient Monitoring Devices
    • 5.4.2. Therapeutic Devices

Chapter 6. Global Wearable Medical Devices Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Wearable Medical Devices Market by Application, Performance - Potential Analysis
  • 6.3. Global Wearable Medical Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Wearable Medical Devices Market, Sub Segment Analysis
    • 6.4.1. Remote Patient Monitoring & Home Healthcare
    • 6.4.2. Sports and Fitness

Chapter 7. Global Wearable Medical Devices Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Wearable Medical Devices Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Wearable Medical Devices Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Wearable Medical Devices Market, Sub Segment Analysis
    • 7.4.1. Retail Pharmacies
    • 7.4.2. Online Distribution
    • 7.4.3. Hypermarkets

Chapter 8. Global Wearable Medical Devices Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Wearable Medical Devices Market, Regional Market Snapshot
  • 8.4. North America Wearable Medical Devices Market
    • 8.4.1. U.S. Wearable Medical Devices Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Wearable Medical Devices Market
  • 8.5. Europe Wearable Medical Devices Market Snapshot
    • 8.5.1. U.K. Wearable Medical Devices Market
    • 8.5.2. Germany Wearable Medical Devices Market
    • 8.5.3. France Wearable Medical Devices Market
    • 8.5.4. Spain Wearable Medical Devices Market
    • 8.5.5. Italy Wearable Medical Devices Market
    • 8.5.6. Rest of Europe Wearable Medical Devices Market
  • 8.6. Asia-Pacific Wearable Medical Devices Market Snapshot
    • 8.6.1. China Wearable Medical Devices Market
    • 8.6.2. India Wearable Medical Devices Market
    • 8.6.3. Japan Wearable Medical Devices Market
    • 8.6.4. Australia Wearable Medical Devices Market
    • 8.6.5. South Korea Wearable Medical Devices Market
    • 8.6.6. Rest of Asia Pacific Wearable Medical Devices Market
  • 8.7. Latin America Wearable Medical Devices Market Snapshot
    • 8.7.1. Brazil Wearable Medical Devices Market
    • 8.7.2. Mexico Wearable Medical Devices Market
  • 8.8. Middle East & Africa Wearable Medical Devices Market
    • 8.8.1. Saudi Arabia Wearable Medical Devices Market
    • 8.8.2. South Africa Wearable Medical Devices Market
    • 8.8.3. Rest of Middle East & Africa Wearable Medical Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Apple Inc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Samsung Electronics Co., Ltd
    • 9.3.3. Garmin Ltd.
    • 9.3.4. Abbott Laboratories
    • 9.3.5. Medtronic plc
    • 9.3.6. Dexcom, Inc
    • 9.3.7. Johnson & Johnson Inc.
    • 9.3.8. Philips Healthcare
    • 9.3.9. Xiaomi Corporation
    • 9.3.10. Intelesens Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦